RANCHO CUCAMONGA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the first quarter ended March 31, 2016.
First Quarter Highlights
- Net revenues of $59.4 million for the first quarter
- GAAP net income of $2.5 million, or $0.05 per diluted share, for the first quarter
- Adjusted non-GAAP net income of $5.5 million, or $0.12 per diluted share, for the first quarter
First Quarter Highlights
- Net revenues of $59.4 million for the first quarter
- GAAP net income of $2.5 million, or $0.05 per diluted share, for the first quarter
- Adjusted non-GAAP net income of $5.5 million, or $0.12 per diluted share, for the first quarter
